Cell Reactant:
Intestinal fatty acid-binding protein (hIFABP)
Syringe Reactant:
BDBM85511
Meas. Tech.:
Enzyme Inhibition
Entry Date.:
10/05/15
ΔG°:
-6.03±0.05 (kcal/mole)
pH:
8±0
Temperature:
310.15±0 (K)
ΔH° :
0.07±0.01 (kJ/mole)
ΔS° :
0.02±0 (kJ/mole-K)
Citation
 Patil, RLaguerre, AWielens, JHeadey, SJWilliams, MLHughes, MLMohanty, BPorter, CJScanlon, MJ Characterization of two distinct modes of drug binding to human intestinal fatty acid binding protein. ACS Chem Biol 9:2526-34 (2014) [PubMed]  Article 
Cell React
Name:
Fatty acid-binding protein, intestinal
Synonyms:
FABP2 | FABPI | FABPI_HUMAN | Fatty acid binding protein intestinal | Fatty acid-binding protein, intestinal | I-FABP | Intestinal fatty acid-binding protein (hIFABP)
Type:
Protein
Mol. Mass.:
15207.56
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
132
Sequence:
MAFDSTWKVDRSENYDKFMEKMGVNIVKRKLAAHDNLKLTITQEGNKFTVKESSAFRNIEVVFELGVTFNYNLADGTELRGTWSLEGNKLIGKFKRTDNGNELNTVREIIGDELVQTYVYEGVEAKRIFKKD
  
Syringe React
Name:
BDBM85511
Synonyms:
CAS_74103-07-4 | KETOROLAC | Ketorolac tris salt | Toradol
Type:
Small organic molecule
Emp. Form.:
C15H13NO3
Mol. Mass.:
255.2686
SMILES:
OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1
Structure:
Search PDB for entries with ligand similarity: